Rift Valley Fever Testing Demand Impelled by Increasing R&D on Discovery of Effective Treatment, Opines Fact.MR
Fact.MR, a global research & consulting firm, in their latest edition of the report, states that the Rift Valley Fever Testing market will foresee a moderate growth pace in 2021 & beyond. The growth can be primarily attributed to increasing incidences of rift valley fever particularly in summer. However, high cost associated with the treatment as well as lack of awareness in relation to RVF amid rural population might create hindrance in the upcoming years.
“Governments are anticipated to boost awareness regarding rift valley fever testing amid rural population as well as encourage R&D activities on the discovery of effective treatment in order to curb the threat of transmission.” states Fact.MR.
Growing Incidences of the Disease Amid the livestock and humans to Driving Demand
Research & development players a vital role in raising the bar for reverse transcriptase polymerase chain reaction (RT-PCR) assay and IgG and IgM enzyme-linked immunosorbent assay (ELISA) by enhancing the quality and increasing ease of use of these testing devices. This would ultimately led to discovery of effective treatment.
Though the disease is reported only in the Middle East and Africa, it could spread easily as well as poses a huge threat to other nations which consecutively will influence the growth of the market. Additionally, growing incidences of the disease amid the livestock in addition to humans is anticipated to drive the demand for rift valley fever testing.
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1096
How Much Do Research Laboratories Contribute Towards Rift Valley Fever Testing?
Driven by increased instances of RVF in humans, research laboratories have continued attaining leading share in the sector in contrast to vetenary clinics and diagnostics centres. Through the course of the forecast period, research laboratoties are expected to register high demand for rift valley fever testing. The outbreak of rift valley fever in addition to other pandemics has been vital at pushing growth in 2021 and beyond. For instance, one of the rift valley fever outbreaks recorded in the Republic of Niger on August 11, 2016, with around 105 suspected instances counting 28 deaths of RVF in humans. This has encouraged an urgent need for R&D for human treatments of RVF.
The US will Continue to Support the Rift Valley Fever Testing Market
The US is projected to remain lucrative region on account of high concentration of major market players. The UK is anticipated to account for the second biggest share in the overall rift valley fever testing market in 2021 and beyond on account of the increasing research & developmental activities.
The Saudi Arabia, Egypt,S. Africa, and N. Africa is anticipated to expand at notable CAGR as a result of growth of rift valley fever product offerings by key players in addition to increasing cases of RVF in humans from these regions.
Request Customized Report
https://www.factmr.com/connectus/sample?flag=RC&rep_id=1096
Increasing Research & Development Activities Remains Key Focus Area: Fact.MR Survey
The rift valley fever testing market is extremely competitive with several players functioning in the global space. Fact.MR’s survey indicated that market players are engaged in discovering effective treatment through research and development in 2021 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are Merck KGaA , Thermo Fisher Scientific, Inc., Promega ,New England Biolabs, Inc., Illumina, Inc, F.Hoffmann-la Roche Ltd. and Agilent Technologies, Inc.The updated edition also offers a detailed analysis of the COVID-19 impact on this market.
Explore Fact.MR’s Healthcare Reports
https://www.factmr.com/report/2820/genetic-testing-panels-market: Delve into Fact.MR’s extensive study on the Genetic testing panels market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.
https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market: The global Drug eluting balloon catheter market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.
https://www.factmr.com/report/867/antibiotic-loaded-bone-cement-market: Fact.MR’s global antibiotic-loaded bone cement market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in Rockville, United States and Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates